FDA Medicare study of elderly patients with atrial fibrillation in a general practice setting who were treated with dabigatran etexilate or warfarin for prevention of stroke.

Trial Profile

FDA Medicare study of elderly patients with atrial fibrillation in a general practice setting who were treated with dabigatran etexilate or warfarin for prevention of stroke.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2014

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Warfarin
  • Indications Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Nov 2014 New trial record
    • 03 Nov 2014 Results published in a Boehringer Ingelheim media release.
    • 30 Oct 2014 Results published online in Circulation, according to a Boehringer Ingelheim media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top